Enhabit Inc.
Enhabit, Inc. provides home health and hospice services in the United States. The company's home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, a… Read more
Enhabit Inc. (EHAB) - Net Assets
Latest net assets as of September 2025: $597.30 Million USD
Based on the latest financial reports, Enhabit Inc. (EHAB) has net assets worth $597.30 Million USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.23 Billion) and total liabilities ($631.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $597.30 Million |
| % of Total Assets | 48.63% |
| Annual Growth Rate | -20.55% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 19.86 |
Enhabit Inc. - Net Assets Trend (2020–2024)
This chart illustrates how Enhabit Inc.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Enhabit Inc. (2020–2024)
The table below shows the annual net assets of Enhabit Inc. from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $553.90 Million | -21.06% |
| 2023-12-31 | $701.70 Million | -9.49% |
| 2022-12-31 | $775.30 Million | -47.73% |
| 2021-12-31 | $1.48 Billion | +6.73% |
| 2020-12-31 | $1.39 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Enhabit Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 62.8% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $98.30 Million | 18.78% |
| Common Stock | $500.00K | 0.10% |
| Other Comprehensive Income | $-200.00K | -0.04% |
| Other Components | $424.90 Million | 81.17% |
| Total Equity | $523.50 Million | 100.00% |
Enhabit Inc. Competitors by Market Cap
The table below lists competitors of Enhabit Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
XiAn ChenXi Aviation Technology Corp Ltd
SHE:300581
|
$505.39 Million |
|
Shenzhen JT Automation Equipment Co Ltd
SHE:300400
|
$505.39 Million |
|
Siteminder Ltd
AU:SDR
|
$505.45 Million |
|
Vivara Participações S.A
SA:VIVA3
|
$505.55 Million |
|
Red Violet Inc
NASDAQ:RDVT
|
$505.33 Million |
|
PMMFF
PINK:PMMFF
|
$505.21 Million |
|
IRISH RES.PPTYS REIT
F:IRES
|
$505.08 Million |
|
Wolfspeed, Inc.
NYSE:WOLF
|
$505.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Enhabit Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 669,700,000 to 523,500,000, a change of -146,200,000 (-21.8%).
- Net loss of 156,200,000 reduced equity.
- Other comprehensive income increased equity by 300,000.
- Other factors increased equity by 9,700,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-156.20 Million | -29.84% |
| Other Comprehensive Income | $300.00K | +0.06% |
| Other Changes | $9.70 Million | +1.85% |
| Total Change | $- | -21.83% |
Book Value vs Market Value Analysis
This analysis compares Enhabit Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.31x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.04x to 1.31x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $354.64 | $13.62 | x |
| 2021-12-31 | $376.92 | $13.62 | x |
| 2022-12-31 | $14.80 | $13.62 | x |
| 2023-12-31 | $13.42 | $13.62 | x |
| 2024-12-31 | $10.43 | $13.62 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Enhabit Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -29.84%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15.09%
- • Asset Turnover: 0.84x
- • Equity Multiplier: 2.34x
- Recent ROE (-29.84%) is below the historical average (-6.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 5.42% | 6.96% | 0.67x | 1.17x | $-63.31 Million |
| 2021 | 7.56% | 10.04% | 0.64x | 1.17x | $-35.90 Million |
| 2022 | -5.45% | -3.77% | 0.70x | 2.06x | $-114.57 Million |
| 2023 | -12.02% | -7.69% | 0.73x | 2.14x | $-147.47 Million |
| 2024 | -29.84% | -15.09% | 0.84x | 2.34x | $-208.55 Million |
Industry Comparison
This section compares Enhabit Inc.'s net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $250,407,165
- Average return on equity (ROE) among peers: -38.80%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Enhabit Inc. (EHAB) | $597.30 Million | 5.42% | 1.06x | $505.38 Million |
| Addus HomeCare Corporation (ADUS) | $113.86 Million | 16.82% | 0.44x | $1.75 Billion |
| agilon health Inc (AGL) | $126.73 Million | -319.84% | 9.03x | $166.17 Million |
| Airsculpt Technologies Inc (AIRS) | $123.68 Million | 6.13% | 0.45x | $16.62 Million |
| Amedisys Inc (AMED) | $454.23 Million | -18.40% | 0.61x | $3.26 Billion |
| AMN Healthcare Services Inc (AMN) | $347.86 Million | 23.54% | 1.53x | $624.22 Million |
| American Shared Hospital Service (AMS) | $20.85 Million | 8.48% | 1.33x | $7.93 Million |
| American Oncology Network Inc. (AONC) | $226.04 Million | -0.05% | 0.10x | $112.23 Million |
| Ardent Health Partners, Inc. (ARDT) | $1.08 Billion | 4.65% | 3.71x | $225.22 Million |
| Arem Pacific Corporation (ARPC) | $-45.09K | 0.00% | 0.00x | $246.12K |
| Astrana Health Inc (ASTH) | $8.55 Million | -109.27% | 1.29x | $1.08 Billion |